I-Beijing Succeeder Technology Inc.

I-Ca²⁺ idlala indima ebalulekile enqubweni yokujiya kwegazi, ikakhulukazi okuhlanganisa izici ezilandelayo:

1. Ukubamba iqhaza ekusebenzeni kwezinto ezibangela ukujiya kwegazi:
Izinto eziningi ezibangela ukujiya zidinga ukubamba iqhaza kwe-Ca²⁺ uma zidlala indima. Isibonelo, enkambisweni yokusebenza kwezinto ezibangela ukujiya IX, X, XI, XII, njll., i-Ca²⁺ iyadingeka ukuthi ibophe kulezi zinto ezibangela ukujiya ukuze zenze izinguquko zokwakheka futhi zidalule isikhungo esisebenzayo, ukuze zikwazi ukusebenzisana nezinye izinto ezibangela ukujiya futhi ziqale ukusabela kwe-coagulation cascade.

2. Khuthaza ukwakheka kwe-coagulation factor complexes:
I-Ca²⁺ ingasebenza njengebhuloho lokukhuthaza ukwakheka kwama-complex phakathi kwama-coagulation factors. Isibonelo, enqubweni yokujiya, i-Ca²⁺ ingaxhuma ama-phospholipid ashajwe kabi (akhona ebusweni be-platelet membranes, njll.) nama-coagulation factors i-Xa, i-V, njll. ukuze kwakhiwe ama-prothrombin complexes, okusheshisa inqubo yokuguqulwa kwe-prothrombin ibe yi-thrombin.

3. Ukusebenza nokukhululwa kwama-platelet:
I-Ca²⁺ nayo ibaluleke kakhulu ekusebenzeni nasekukhululeni ukusabela kwama-platelet. Lapho imithambo yegazi yonakele, ama-platelet anamathela engxenyeni eyonakele, bese i-Ca²⁺ ingena kuma-platelet, okubangela uchungechunge lokusabela kwamakhemikhali kuma-platelet, okuholela ekukhishweni kwezinto ezahlukahlukene ezisebenzayo kuma-platelet, njenge-adenosine diphosphate (ADP), i-thromboxane A₂, njll. Lezi zinto zithuthukisa ukuhlanganiswa kwama-platelet kanye nokujiya kwegazi.

4. Qinisa ama-polymer e-fibrin:
Esigabeni sokugcina sokujiya, i-fibrinogen iguqulwa ibe ama-monomer e-fibrin ngaphansi kwesenzo se-thrombin, bese ama-monomer e-fibrin exhunyaniswe ukuze akhe ama-polymer e-fibrin azinzile ngaphansi kwesenzo se-Ca²⁺ kanye ne-coagulation factor XIII, ngaleyo ndlela akha i-blood clot eqinile ukuze kufezwe injongo ye-hemostasis. Ngaphandle kwe-Ca²⁺, ama-monomer e-fibrin awakwazi ukuxhunyaniswa abe ama-polymer e-fibrin azinzile, ama-blood clot awakwazi ukwakheka ngempumelelo, futhi igazi alikwazi ukujiya ngokujwayelekile.

I-Beijing Succeeder Technology Inc. (Ikhodi yesitoko: 688338), eyasungulwa ngo-2003 futhi yafakwa ohlwini kusukela ngo-2020, ingumkhiqizi ohamba phambili ekuxilongweni kwe-coagulation. Singochwepheshe ekuhlaziyeni kwe-coagulation okuzenzakalelayo kanye nama-reagent, abahlaziyi be-ESR/HCT, kanye nabahlaziyi be-hemorheology. Imikhiqizo yethu iqinisekiswe ngaphansi kwe-ISO 13485 kanye ne-CE, futhi siphakela abasebenzisi abangaphezu kwe-10,000 emhlabeni jikelele.

Isingeniso Sokuhlaziya
Isihlaziyi se-Coagulation Esizenzakalelayo Ngokugcwele i-SF-9200 (https://www.succeeder.com/fully-automated-coagulation-analyzer-sf-9200-product) singasetshenziswa ekuhlolweni kwezokwelapha kanye nokuhlolwa kwangaphambi kokuhlinzwa. Izibhedlela kanye nabacwaningi besayensi yezokwelapha nabo bangasebenzisa i-SF-9200. Esebenzisa i-coagulation kanye ne-immunoturbidimetry, indlela ye-chromogenic yokuhlola i-clotting ye-plasma. Ithuluzi libonisa ukuthi inani lokulinganisa i-clotting yisikhathi sokujiya (ngemizuzwana). Uma into yokuhlola ilinganiswa yi-plasma yokulinganisa, ingabonisa neminye imiphumela ehlobene.
Lo mkhiqizo wenziwe ngeyunithi enyakazayo ye-probe yokubonisa isampula, iyunithi yokuhlanza, iyunithi enyakazayo yama-cuvettes, iyunithi yokushisa nokupholisa, iyunithi yokuhlola, iyunithi eboniswa ukusebenza, isikhombimsebenzisi se-LIS (esetshenziselwa iphrinta nosuku lokudlulisela kwiKhompyutha).
Abasebenzi bezobuchwepheshe nabanolwazi kanye nabahlaziyi bekhwalithi ephezulu kanye nokuphathwa kwekhwalithi okuqinile bayisiqinisekiso sokukhiqizwa kwe-SF-9200 kanye nekhwalithi enhle. Siqinisekisa ukuthi ithuluzi ngalinye lihlolwe futhi lihlolwe ngokuqinile. I-SF-9200 ihlangabezana nezindinganiso zikazwelonke zaseShayina, amazinga emboni, amazinga ebhizinisi kanye nezindinganiso ze-IEC.